1. Home
  2. ATEN vs SPRY Comparison

ATEN vs SPRY Comparison

Compare ATEN & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATEN
  • SPRY
  • Stock Information
  • Founded
  • ATEN 2004
  • SPRY 2015
  • Country
  • ATEN United States
  • SPRY United States
  • Employees
  • ATEN N/A
  • SPRY N/A
  • Industry
  • ATEN EDP Services
  • SPRY Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATEN Technology
  • SPRY Health Care
  • Exchange
  • ATEN Nasdaq
  • SPRY Nasdaq
  • Market Cap
  • ATEN 1.3B
  • SPRY 1.1B
  • IPO Year
  • ATEN 2014
  • SPRY N/A
  • Fundamental
  • Price
  • ATEN $17.61
  • SPRY $8.66
  • Analyst Decision
  • ATEN Strong Buy
  • SPRY Strong Buy
  • Analyst Count
  • ATEN 4
  • SPRY 4
  • Target Price
  • ATEN $21.50
  • SPRY $31.25
  • AVG Volume (30 Days)
  • ATEN 425.6K
  • SPRY 1.7M
  • Earning Date
  • ATEN 11-04-2025
  • SPRY 11-10-2025
  • Dividend Yield
  • ATEN 1.37%
  • SPRY N/A
  • EPS Growth
  • ATEN 21.29
  • SPRY N/A
  • EPS
  • ATEN 0.69
  • SPRY N/A
  • Revenue
  • ATEN $276,445,000.00
  • SPRY $112,339,000.00
  • Revenue This Year
  • ATEN $10.53
  • SPRY N/A
  • Revenue Next Year
  • ATEN $7.41
  • SPRY $193.13
  • P/E Ratio
  • ATEN $25.34
  • SPRY N/A
  • Revenue Growth
  • ATEN 11.04
  • SPRY 22367.80
  • 52 Week Low
  • ATEN $13.81
  • SPRY $8.32
  • 52 Week High
  • ATEN $21.90
  • SPRY $18.90
  • Technical
  • Relative Strength Index (RSI)
  • ATEN 46.39
  • SPRY 34.69
  • Support Level
  • ATEN $17.31
  • SPRY $8.32
  • Resistance Level
  • ATEN $17.95
  • SPRY $9.01
  • Average True Range (ATR)
  • ATEN 0.45
  • SPRY 0.52
  • MACD
  • ATEN -0.01
  • SPRY -0.09
  • Stochastic Oscillator
  • ATEN 42.86
  • SPRY 13.48

About ATEN A10 Networks Inc.

A10 Networks Inc is a provider of security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments of its multinational enterprise, communication, cloud and web service provider customers who strive to provide business-critical applications and networks that are secure, available, and efficient. As cyber-attacks increase in volume and complexity, the company integrates security and artificial intelligence (AI) enabled capabilities in its solutions that enable its customers to continue to adapt to market trends in hybrid cloud, AI-ready data centers and the ever-increasing need for high-performance, high availability and low latency. The company generates the maximum of its revenue from Americas.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: